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Abstract
An anaerobic three-stage continuous culture model of the human colon (gut model), which represent different anatomical
areas of the large intestine, was used to study the effect of S. aureus infection of the gut on the resident faecal microbiota.
Studies on the development of the microbiota in the three vessels were performed and bacteria identified by culture
independent fluorescence in situ hybridization (FISH). Furtheremore, short chain fatty acids (SCFA), as principal end products
of gut bacterial metabolism, were measured along with a quantitative assessment of the predominant microbiota. During
steady state conditions, numbers of S. aureus cells stabilised until they were washed out, but populations of indigenous
bacteria were transiently altered; thus S. aureus was able to compromise colonisation resistance by the colonic microbiota.
Furthermore, the concentration of butyric acid in the vessel representing the proximal colon was significantly decreased by
infection. Thus infection by S. aureus appears to be able to alter the overall structure of the human colonic microbiota and
the microbial metabolic profiles. This work provides an initial in vitro model to analyse interactions with pathogens.
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Introduction
Staphylococcus aureus is a major opportunistic human pathogen,
able to cause a wide variety of disease in humans and animals.
It is the cause of a large burden of morbidity and mortality,
globally, in both hospital and community settings [1]. Despite the
plethora of antimicrobial agents available, infection continues to
spread and many strains are resistant to an array of antibiotics. In
particular, methicillin resistant S. aureus (MRSA) is an acute clinical
problem, with many hospital and community isolates displaying
resistance [1]. In response, measures have been developed to
prevent the spread of this naturally ubiquitous organism, which
lives as a commensal in the nares of 20–25% of the population at
any one time [2,3]. While nasal colonisation is a well-established
risk factor for most types of infections, several recent studies have
suggested that colonisation of the intestines, which occurs in c.
20% of individuals and which relatively, has been less intensively
studied, could have important clinical implications [4]. Patients
with S. aureus intestinal colonisation may serve as an important
source of transmission, as they often contaminate the adjacent
environment [5]. Factors such as faecal incontinence and diarrhea
contribute to dissemination of the pathogen in the healthcare
environment [6]. Similarly, such patients display increased
frequencies of skin colonisation [7] and studies in intensive care
and liver transplant units have shown that patients colonised by
MRSA at the rectum and nares have a significantly higher risk of
disease than patients with nasal colonisation alone [8]. Further-
more, hospitalised patients reported co-colonisation by S. aureus
and vancomycin-resistant enterococci in .50% of the individuals
studied [6]. Thus, intestinal colonisation by S. aureus provides the
pathogen with the opportunity to acquire new antibiotic resistance
genes.
The clinical implications of intestinal colonisation by S. aureus are
still relatively ill-defined. It is assumed that carriage imposes a risk
for intestinal infection. S. aureus can induce psuedomembranous
colitis that is histologically distinct from that caused by Clostridium
difficile [9]. Several studies have shown that intestinal colonisation
occurs frequently in infants, particularly those that have been
breast-fed [10] and is positively correlated with development of
allergies and increased expression levels of the soluble immune
modulator CD14, in such children [11–15]. The role of intestinal
carriageindevelopmentofsystemicS.aureusdiseasehasnotyetbeen
established. However in mice, colonisation of the intestinal lumen
can lead to S. aureus crossing the intestinal epithelial barrier and
subsequent spread to the mesenteric lymph nodes [16,17].
The human intestine represents a complex ecosystem with
many commensal microflora species, various types of secretory
fluids, fermentation metabolites of digested food and host defense
molecules [18]. Survival and subsequent successful colonisation of
pathogenic bacteria in the human intestinal tract requires them to
resist innate defenses in the intestine. Colonisation resistance by
normal commensal bacteria, acidic pH, fermentation metabolites
like short chain fatty acids (SCFA), high osmolarity, local gut
mucosal immunity by host defense molecules and bile acids in the
intestine represent major obstacles for the survival and colonisa-
tion of invading pathogenic bacteria.
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carriage and survival of S. aureus in the human intestine.
Laboratory mouse models of infection do not reproduce the
complex microbial ecosystem or the physicochemical environment
of the human gut [19].
An in vitro three-stage continuous culture system (gut model) is a
useful tool to monitor the ecology and metabolic activities of the
microbiota in the proximal, transverse and distal colon, in
particular in relation to different environmental conditions, dietary
intervention, as well as administration of drugs and antimicrobials
[20,21]. In this study, we investigated the impact of S. aureus on the
normal intestinal flora, and survival of the pathogen, using a three-
stage continuous culture model system of the human colon. We
found that infection had a significant impact on the normal colonic
microflora. Futhermore, short chain fatty acids (SCFA) generation,
end products of gut bacterial metabolism, were measured and
found to be altered significantly by the presence of S. aureus. Thus
S. aureus is able to influence the composition in the human gut, of
both the microbiota and SCFAs.
Results
Survival of S. aureus in a continuous culture model of the
human gut
An in vitro three-stage culture system was used to model the
conditions found in the human colon (Figure 1). Post-infection
survival of S. aureus in three independent in vitro colonic models was
quantified by viable colony count methods using selective BHI; all
colonies displayed identical morphology. Prior to S. aureus
inoculation into V1 of each colonic model, colony counts at SS1
revealed absence of detectable S. aurues in the colonic models
(Figure 2A). After inoculating the colonic models with S. aureus to a
concentration of c. 2610
10 CFU/mL, as a single dose, the S. aureus
populations stabilised at 6 to 7 Log10 units over a period of 4 and
6 h in all the three vessels of colonic models (Figure 2A). Sub
populations of 3 to 4 Log10 units were found over a period of 24,
48, and 72 h in all three vessels and less than 2 to3 Log10 units
counts were found at 96 h after initial inoculation (Figure 2A). No
S. aureus was detected in any of the three vessels at SS2.
S. aureus populations were also quantified by FISH, using a Cy3
labelled-16S rRNA targeted oligonucleotide probe specific to S.
aureus. Enumeration of S. aureus populations by FISH revealed
similar patterns of survival in all the three vessels compared to the
viable colony count method, although some differences occur due
to the higher threshold of detection of FISH. The absence of S.
aureus from the faecal samples used, was confirmed prior to the
inoculation of S. aureus into the colonic models at SS1. After the
initial inoculation, S. aureus achieved stabilsing populations of 7 to
8 Log10 units over a period of 4, 6, and 24 h (Figure 2B). No
bacteria were detected at 24 h after inoculation due to a lower
detection limit (6 Log10 CFU/mL) of the FISH method. In one
gut model, 2 to 3 Log10 units of S. aureus were present after 48 h, in
all three vessels (Figure 2B). Such variations in the survival could
be influenced by indigenous faecal microflora and dietary habbits
of the donors who contributed faecal samples for the study.
S. aureus colonies recovered on the selective agar were confirmed
by PCR amplification using oligonucleotide primers specific to S.
aureus specific genes. Interogation of the J. Craig Venter Institute
Comprehensive Microbial Resource (http://cmr.jcvi.org) con-
firmed that efb (extracellular fibronogen binding protein) and spa
Figure 1. Schematic diagram of the in vitro three-stage culture colonic model system (human colonic model). Each vessel was
continually sparged with O2 free N2. The pH of each vessel was individually maintained via automated addition of 1M HCl or 1M NaOH, as required.
The system was maintained at 37uC and stirred continuously.
doi:10.1371/journal.pone.0023227.g001
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S. aureus strains. PCR products c. 0.5 and 1.5 kb representing efb
and spa respectively, confirmed that the recovered colonies were
indeed S. aureus (results not shown).
Impact of S. aureus survival on the colonic microbiota
composition
The effect of S. aureus survival on the 6 major colonic
commensal bacterial groups, were determined for each vessel at
SS1 (prior to the inoculation of S. aureus into colonic models) and 0,
4, 6, 24, 48, 72, and 96 h post inoculation as well as at SS2 by
FISH. In all three model vessels, Bacteroides group (Bac303) was the
predominant group at SS1, followed by Eubacterium rectale/
Clostridium cluster XIVa (Erec482), Bifidobacterium (Bif164), Clostrid-
ium histolyticum (Chis150), and Lactobacillus (Lab158) (Figures 3A, 3B
and 3C). A different behaviour was determined for the levels of
Bifidobacterium, Bacteroides, Lactobacillus and total bacteria (Eub-mix)
in all three vessels and Eubacterium rectale/Clostridium cluster XIVa
for V3 (Figures 3A, 3B and 3C). FISH analysis showed that
Bifidobacterium, a predominant health-promoting genus of the
human gut microbiota [22,23], decreased significantly from 4 to
96 h post inoculation (P,0.05) in V1, 6 to 72 h post inoculation
(P,0.05) in V2, and 4 to 72 h post inoculation (P,0.05) in V3. At
SS2, the bifidobacterial counts reverted back to the levels found in
SS1.
Bacteroides, another common genus of human gut microbiota
involved in colonisation resistance to enteric pathogens [24], also
decreased significantly from 4 to 48 h post inoculation (P,0.05) in
all the three vessels and counts reverted back to the normal levels
at SS2 as found in SS1. Lactobacillus counts decreased significantly
only at 4 h post inoculation (P,0.05) and reverted back to normal
levels there onwards in all three vessels. Total bacterial counts
decreased significantly from 4 to 48 h post inoculation (P,0.05) in
V1 and V2, and 4 to 24 h post inoculation (P,0.05) in V3. Total
bacterial counts reverted back to normal levels at SS2 as found in
SS1. A significant decrease in the Eubacterium rectale/Clostridium
cluster XIVa counts were determined at 4 to 24 h post inoculation
(P,0.05) in V3 only and no significant differences in the counts
were found in V1 and V2 throughout the experiments. Clostridium
histolyticum did not show any significant modification in counts at
SS1 and post inoculation periods in all three vessels.
Impact of S. aureus survival on the SCFA production in
the colonic models
Profiles of SCFAs concentrations prior to the S. aureus
inoculation (SS1) and during different time periods of post
inoculation quantified by gas chromatography are shown in
Figure 4. Acetate was the predominant SCFA detected during SS1
and through out different time periods of post inoculation,
followed by propionate and butyrate in all three vessels. Significant
differences in SCFA profiles were detected only in V1(Figure 4A),
whereas changes in the SCFA profiles were insignificant during
SS1 and different time periods of post inoculation in V2 and V3
(Figure 4B and 4C). Acetate concentrations decreased significantly
from 48 to 96 h post inoculation (P,0.01), whereas decreases in
concentrations at 24 h and SS2 were not significant in V1.
Propionate levels decreased significantly from 24 to 96 h post
inoculation and even at SS2 (P,0.01) in V1. Similarly, butyrate
concentrations also decreased signifcantly from 24 to 96 h post
inoculation (P,0.05) in V1. Total SCFA levels also decreased
significantly from 24 to 96 h post inoculation (P,0.01). The
difference between SS1 and SS2 in V1 was not statistically
significant (Figure 4A). None of the changes in concentrations of
acetate, propionate, butyrate, and total SCFAs in V2 and V3 were
significant at any time point, when compared to SS1 (Figure 4B
and 4C).
Discussion
S. aureus is able to colonise multiple niches within humans. In
doing so, the host is at significantly increased risk of developing
disease. Colonisation of the human nares is a well studied risk
factor which can predispose an individual to subsequent infection
with the same strain [25]. Similarly, S. aureus rectal colonisation
imparts an increased risk of disease [8]. Interestingly, USA300 S.
aureus strains, which are responsible for a current outbreak of
community acquired disease in the United States, colonise the
rectum at rates higher than the nose [26]. A recent study to
determine S. aureus genetic traits associated with these observed
higher rectal carriage rates was inconclusive [27]. Thus it would be
very interesting to study the effect that these strains have on gut
microbial ecology.
Figure 2. S. aureus populations detected in culture broths
recovered from the three different vessels (V1, V2 and V3) of
the colonic model before (SS1) and after (0, 4, 6, 24, 48, 72, and
96 h and SS2) inoculation of S. aureus by viable plate count (A)
and FISH method (B). Results are reported as means (Log10 CFU/mL)
of the data of three colonic models 6 standard error of mean. The
apparent
doi:10.1371/journal.pone.0023227.g002
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whose diverse microbiota profoundly affects health of the host. It
provides digestive functions, modulates host metabolism and
stimulates angiogenesis, development of lymphatic tissue and the
mucosal immune system [28]. Importantly, it can limit infection of
the gut by other bacteria. This network of interactions is believed
to stabilise the structure of the microbiota population and inhibit
colonisation by invading pathogens [29]. Molecular interactions
between different members of the microbiota, which prevent
establishment of pathogen colonisation, remain to be determined.
However, some pathogens are able to disrupt this colonisation
resistance and infect the gut [29]. Similarly, the mechanisms that
pathogens use to overcome these barriers, formed by the intrinsic
microbiota, are poorly understood.
The intestinal microflora is able to ferment plant materials, such
as celluloses, starches and sugars, which have been consumed by
the host. Mammals lack the necessary enzymes to split such
compounds and rely on microbial fermentation to convert
indigestible carbohydrates and oligosaccharides into SCFAs, a
process which occurs mainly in the proximal colon [30]. In the
human colon, acetic, propionic and butyric acids predominate. Of
these, butyrate has been particularly well studied because of the
effects that it can have on gut health. Metabolism of butyrate
represents the preferred energy source for colonocytes and is
responsible for synthesis of many key components of the intestinal
epithelium [31,32].
SCFAs such as acetate, propionate and butryate are weak acids
with bacteriostatic and bactericidal properties which, in part,
depend on the physiological status of the bacteria and the physico-
chemical characteristics of the external environment. They can
influence the pattern of gene expression in bacteria. Studies on
Salmonella typhimurium and Salmonella enteritidis have shown that
SCFAs specifically downregulate genes of the Salmonella pathoge-
nicity island (SPI)-1 [33], resulting in supressed invassion of
epithelial cells. Conversely, butyrate has been shown to enhance
expression of virulence associated genes in enterohaemorrhagic
Escherichia coli [34].
In addition to direct effects on pathogenic bacteria, SCFAs are
able to induce pathogen resistance in host cells [30]. Butyrate
treatment of human epithelial cells has been shown to induce
resistance to bacterial invasion by Campylobacter jejuni or S. aureus
[35,36]. Furthermore, butyrate treated epithelial cells produce
increased levels of antimicrobial peptides and nitric oxide [36].
Our study demonstrates that S. arueus is able to survive the
microbial environment of the human gut. Addition of S. aureus to
the model to mimic infection, resulted in a significant, transient
decrease in the numbers of eubacteria and specifically Bacteroides,
Bifidobacterium and Lactobacillus/Enterococcus species in vessels 1 and
2, which simulate the proximal and transverse colons, respectively.
In vessel 3, which reflects conditions in the distal colon, a broader
impact on the microbiota was observed; this involving significant
decreases in all of the genera or species measured, except for
Clostridium histolyticum. The mechanisms by which S. aureus is able to
colonise the human gut remain poorly understood, however it is
now well recognised that a healthy resident microbiota provides
good protection against invading pathogens. Given the findings of
Figure 3. Major colonic bacterial groups detected by FISH in
the culture broths recovered from the vessel 1 (A), vessel 2 (B),
and vessel 3 (C) of the colonic model before (SS1) and after (0,
4, 6, 24, 48, 72, and 96 h and SS2) inoculation of S. aureus.
Results are reported as means (Log10 CFU/mL) of the data of three
colonic models 6 standard error of mean. For each colonic model,
measurements were performed in triplicate at SS1 (days 11, 12 and 13)
and SS2 (days 21, 22 and 23). *P,0.05.
doi:10.1371/journal.pone.0023227.g003
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bacteria in order to acquire a niche. The eventual loss of
detectable levels of S. aureus from the model is assumed to be the
result of washout from the continuous culture system which is
constantly fed with growth medium.
Decreased butyrate in V1 is presumed to result from the altered
microbiota, some members of which carry out the conversion of
complex molecules to SCFAs. The effect that butyrate has on S.
aureus remains unknown. While butyrate is bactericidal for some
species, it has recently been reported to have no effect on S. aureus
at neutral pH. However, SCFAs possess increased potency at low
pH and any effect of butyrate on S. aureus physiology in conditions
of the proximal colon (pH 5.5), remains to be determined.
Furthermore, decreased butyrate concentrations in the human
colon could result in increased localised inflammation, which is
believed to facilitate pathogen colonisation [37–40].
The complex, beneficial interplay between the host and its
microbiota can be interupted by pathogenic bacteria. However
any invading pathogen must perturb this delicate association in
order to overcome resistance and subsequently colonise and persist
within its host. In this study we have demonstrated that S. aureus is
able to disrupt the normal microbiota of the human colon. The
physiological adaptations made by the pathogen in order that it
can colonise the gut, remain to be determined.
Materials and Methods
Bacteria and Growth conditions
The routinely used laboratory strain S. aureus SH1000 [41] was
grown on Brain Heart Infusion (BHI) (Oxoid) agar at 37uC.
Three-stage continuous culture colonic model system
(human colonic model)
The three-stage continuous culture model of the human colon
comprised of three glass fermenters of increasing working volume,
simulating the proximal (V1, 280 mL), transverse (V2, 300 mL)
and distal colonic areas (V3, 320 mL). The three fermenters were
connected in series, which fed into each other sequentially and
finally overflowing into a waste vessel. All vessels were kept at
37uC by means of a circulating water-bath. The pH was controlled
and held at 5.5 (V1), 6.2 (V2) and 6.8 (V3) and the system was kept
anaerobic by continuously sparging with oxygen free nitrogen gas
(15 mL/min). Faecal healthy human samples were collected on
site, kept in an anaerobic cabinet (10% H2, 10% CO2, 80% N2)
and used within a maximum of 15 min after collection. This
experiment was carried out in triplicate using faecal samples from
three different volunteers (one faecal donor for each experimental
set up). After obtaining verbal informed consent, a standard
questionnaire to collect information regarding the health status,
drugs use, clinical anamnesis, and lifestyle was administrated
before the donor was ask to provide a faecal sample. The
University of Reading ethics committee exempted this study from
review because no donors were involved in any intervention and
waived the need for written consent due to the fact the samples
received were not collected by means of intervention. None of the
volunteers had received antibiotics or probiotics for at least 3
months before sampling, or steroids or other drugs with a proven
Figure 4. Short-chain fatty acids concentrations in the culture
broths recovered from the vessel 1 (A), vessel 2 (B), and vessel
3 (C) of the colonic model before (SS1) and after (24, 48, 72,
and 96 h and SS2) inoculation of S. aureus. Results are reported as
means (mM) of the data of three colonic models 6 standard error of
mean. For each colonic model, measurements were performed in
triplicate at SS1 (days 11, 12 and 13) and SS2 (days 21, 22 and 23).
*P,0.05; **P,0.01.
doi:10.1371/journal.pone.0023227.g004
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weeks. A 1:5 (w/w) dilution in anaerobic PBS [0.1 mol/L PBS
(pH 7.4)] was prepared and the samples were homogenized in a
stomacher (Seward, Worthing, UK) for 2 min. Each vessel was
inoculated with 100 mL faecal slurry. Total system transit time
was set at 36 h. V1 was fed by means of a peristaltic pump with
complex colonic model medium as previously reported [21].
Following inoculation, the colonic model was run as a batch
culture for a 24 h period in order to stabilise bacterial populations
prior to or the initiation of medium flow. After 24 h (T0) the
medium flow was initiated and the system was run for eight full
volume turnovers to allow steady state to be achieved (SS1). At
SS1, samples were obtained on three consecutive days to confirm
steady state status by SCFA and fluorescence in situ hybridisation
(FISH) based analyses of the microbiota. After the establishment of
SS1, V1 of the colonic model was inoculated with S. aureus
SH1000 (c.2 610
10 CFU/ml) as a single dose, suspended in
colonic model media. Three samples were taken from each vessels
of the colonic model at SS1, 0, 4, 6, 24, 48, 72 and 96 h after
inoculation with S. aureus for viable plate counting and FISH
analysis of major colonic bacteria. Samples were also collected on
three consecutive days as described for SS1 for a further full eight
volume turnovers upon which steady state 2 (SS2) was achieved.
Samples for FISH were fixed immediately in 4% paraformalde-
hyde as previously described [42]. Another set of samples collected
at SS1, 24, 48, 72, and 96 h after S. aureus inoculation as well as at
SS2 were centrifuged at 13000 g and the supernatant stored at
220uC for gas chromatography analysis.
Enumeration of S. aureus on selective agar
Samples (100 ml) of the experimental sets at times SS1, 0, 4, 6,
24, 48, 72, and 96 h after infection as well as at SS2 from all three
vessels of the in vitro colonic model were plated onto BHI agar
containing 0.01% (w/v) potassium tellurite as a selective agent at
different dilutions (from 10
2 to 10
9 CFU/ml) in triplicate for each
time point to measure bacterial growth. Dilutions were prepared
using phosphate buffered saline (PBS). The lowest dilution that
had bacterial colonies growing on it was used to calculate CFU/
mL. As all dilutions were carried out in triplicate, the mean of their
log10 was calculated (Log10 CFU/mL =n6506dilution factor; n
= the number of colonies counted).
Species- specific PCR analysis
A random selection of single colonies from selective agar plates
was inoculated into 10 ml BHI and grown overnight at 37uC. One
mL of overnight culture was harvested and DNA samples
extracted using the DNeasy Blood and Tissue kit (Qiagen).
Extracted bacterial DNA was quantified using a NanoDrop ND-
1000 Spectrophotometer (NanoDrop 116 Technologies, Wilming-
ton, DE, USA) and stored at 220uC. The primers (synthesised by
Eurofins, Germany) used and the PCR conditions were described
in Table 1.
Enumeration of major colonic bacterial populations by
Fluorescence in Situ Hybridization (FISH)
FISH experiments were performed as previously described [42].
All probes were Cy3-labelled and synthesized by Sigma Aldrich
(Sigma-Aldrich, UK). Table 2 gives the details of the probes used
in this study. The composition of hybridization and wash buffers
depends on the rRNA-targeted oligonucleotide probe as reported
in probeBase (http://www.microbial-ecology.net/probebase) and
was used accordingly.
Short chain fatty acids analysis (SCFA) by gas
chromatography
Aliquots of 1 mL collected from each vessel in microcentrifuge
tubes were centrifuged at 13000 g for 5 min. The supernatants
were transferred into fresh microcentrifuge tubes and stored at
220uC until use. Samples were derivatized as previously described
[43]. Briefly, the supernatants stored at 220uC were thawed on ice
and centrifuged at 13000 g for 10 min. 500 ml of each supernatant
was transferred into fresh microcentrifuge tubes and 25 mLo f
internal standard (2-ethyl butyric acid) followed by 250 mlo f
concentrated HCl and 1 mL of ether added to each of the tubes.
Tubes were vortexed for 1 min and centrifuged at 3000 g for
10 min. The top ether layer was collected and transferred into
fresh microcentrifuge tubes. Aliquots (400 ml) of the ether extract
were pipetted into a Wheaton vial and then 50 mlo fN -
tertButyldimethyl silyl N-methyltrifluoroacetamide (MTBSTFA)
was added. The vials were sealed tightly by screwing after addition
of MTBSTFA and heated at 80uC for 20 min in a water bath.
Samples were transferred to Agilent crimp cap vials for gas
chromatography analysis. Vials were capped with Crimp top
natural rubber/PTFE seal type 7 aluminium silver 11 mm
Chromacol caps and sealed using a crimper. The capped vials
were left at room temperature for 48 h for derivatization.
Calibration was achieved using standard solutions of derivatized
acetic, propionic, i-butyric, n-butyric, i-valeric, n-valeric, and n-
caproic acids as described for test samples. The final concentra-
tions of each standard was 25, 10, 5, 1, and 0.5 mM. The
derivatized samples were run through a 5890 series II GC system
(HP, Crawley, West Sussex, UK) fitted with SGE-HT5 column
(0.32 mm625 m60.1 mm; J&W Scientific, Folsom, CA, USA) and
flame ionisation detector. Helium was used a carrier gas and
delivered at a flow rate of 14 mL/min. The head pressure was set
at 10 psi with split ratio 10:1. Injector, column and detector were
set at 275, 250 and 275uC respectively. One micro liter quantity of
each sample was injected with a run time of 10 min. Peaks were
integrated using the Atlas Lab managing software (Thermo Lab
Systems, Mainz, Germany). Fatty acid concentrations were
Table 1. Primers and PCR conditions for colony screening.
Gene Oligonucleotide sequences (59 to 39) PCR product size PCR conditions
efb CGTCAACAGCACATATGAGCGAAGGATACG
GCAACGATTGAACTCGAGTTTAACTAATCC
c. 0.5 kb 1 min at 95uC; 30 cycles:
1 min at 95uC, 1 min at 59uC,
1 min at 72uC, and finally 2 min at 72uC
spa CTAGGTGTAGGTATTGCATC
CGCTGCACCTAAGGCTAATG
c. 1.5 kb 1 min at 95uC; 30 cycles:
1 min at 95uC, 1 min at 51uC,
1 min at 72uC, and finally 2 min at 72uC
doi:10.1371/journal.pone.0023227.t001
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expressed in mM.
Statistical Analysis
All data were analyzed by a One-Way Anova method, using the
Tukey post test analysis when overall P of the experiment is below
the value of significance (P,0.05). Additional paired t-test was
applied to understand significance of results of single pairs of data.
Analyses were performed using GraphPad Prism 5.0 (GraphPad
Software Inc., La Jolla, CA, USA).
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